Bacterin International Holdings Inc (OTCQX US:BONE)

3.65
Delayed Data
As of 11:58am ET
 +0.02 / +0.55%
Today’s Change
2.19
Today|||52-Week Range
8.10
+20.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$25.6M

Company Description

Bacterin International Holdings, Inc. develops, manufactures and markets biologics products to domestic and international markets. Its bone graft products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain through facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries. The company acellular dermis scaffolds are utilized in wound care and plastic and reconstructive procedures. It also develop custom surgical instruments for use with its allografts, and it produce and distribute OsteoSelect DBM putty, an osteoinductive product used by surgeons as a bone void filler in the extremities and pelvis. The company was founded by Guy S. Cook in 1998 and is headquartered in Belgrade, MT.

Contact Information

Bacterin International Holdings, Inc.
600 Cruiser Lane
Belgrade Montana 59714
P:(406) 388-0480
Investor Relations:

Employees

Shareholders

Other institutional8.52%
Individual stakeholders1.93%
Mutual fund holders0.29%

Top Executives

Daniel S. GoldbergerChief Executive Officer & Director
Robert M. Di SilvioPresident
Darrel L. HolmesChief Operating Officer
John P. GandolfoChief Financial Officer, Secretary & Treasurer
Gregory A. JudaChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account